Fresenius SE & Co. KGaA



Fresenius - the health care group

Fresenius is a global health care group with products and services for dialysis, the hospital and the medical care of patients at home.

The Fresenius Group consists of the following four business segments that are responsible for their own business operations worldwide: Fresenius Medical Care, Fresenius KabiFresenius Helios and Fresenius Vamed.

Latest news

Moody’s upgrades Fresenius’ credit rating to investment grade

Moody’s Investors Service has upgraded the corporate credit rating of Fresenius from Ba1 to Baa3 with a stable outlook.

Continued strong sales and net income growth – Fresenius raises Group earnings guidance for 2015

Ulf Mark Schneider, CEO of Fresenius, said: “Our strong growth trend continued with double-digit constant currency sales and earnings growth in the first nine months. All business segments contributed to the excellent financial results. (...)”

Fresenius Medical Care reports third quarter 2015 results and confirms guidance for full year 2015
Rice Powell, chief executive officer of Fresenius Medical Care stated: “With the dynamic growth in our Care Coordination business and our continued strong operating performance in our core businesses, we are well positioned for future success. We are very satisfied with our accomplishments in the third quarter despite the unfavorable currency impacts. [...]"
Fresenius successfully places U.S. dollar denominated Senior Notes
Fresenius successfully placed US$300 million of senior unsecured notes with a maturity of 7 years. >>>
Fresenius announces offering of U.S. dollar denominated Senior Notes
Fresenius intends to issue US$300 million of senior unsecured notes with a maturity of 7 years. The proceeds of this offering will be used to refinance short-term debt, extending our maturity profile. >>>